ClinVar Miner

Submissions for variant NM_000548.5(TSC2):c.4858C>T (p.His1620Tyr)

dbSNP: rs45446901
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001383217 SCV001582300 pathogenic Tuberous sclerosis 2 2020-07-20 criteria provided, single submitter clinical testing This variant has been observed in individual(s) with tuberous sclerosis complex (PMID: 16114042, 10533067). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 49327). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TSC2 protein function. This variant is not present in population databases (ExAC no frequency). This sequence change replaces histidine with tyrosine at codon 1620 of the TSC2 protein (p.His1620Tyr). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and tyrosine.
Tuberous sclerosis database (TSC2) RCV000042587 SCV000066381 not provided Tuberous sclerosis syndrome no assertion provided curation
PreventionGenetics, part of Exact Sciences RCV004724772 SCV005336116 likely pathogenic TSC2-related disorder 2024-07-24 no assertion criteria provided clinical testing The TSC2 c.4858C>T variant is predicted to result in the amino acid substitution p.His1620Tyr. This variant has been reported in two individuals with tuberous sclerosis and occurred de novo in one of the individuals (Table 2. Niida et al. 1999. PubMed ID: 10533067; Table 1. Rendtorff et al. 2005. PubMed ID: 16114042). This variant has also been reported to occur de novo in a prenatal specimen within a study investigating noninvasive prenatal diagnosis of tuberous sclerosis.  The child was reported healthy at 2 1/2 years old in a follow-up (Yang et al. 2022. PubMed ID: 35429229). Different amino acid changes at the same codon, c.4859A>G (p.His1620Arg) and c.4859A>T (p.His1620Leu), have been reported as likely pathogenic in ClinVar (ClinVar IDs: 424510, 65243). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/49327/). This variant is interpreted as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.